Literature DB >> 11399172

Structure, stability, and interconversion barriers of the rotamers of cis-[Pt(II)Cl(2)(quinoline)2] and cis-[Pt(II)Cl(2)(3-bromoquinoline)(quinoline)] from X-ray crystallography, NMR spectroscopy and molecular mechanics evidence.

M S Davies1, C I Diakos, B A Messerle, T W Hambley.   

Abstract

Reported are the preparations of cis-[PtCl(2)(quinoline)(2)] and cis-[PtCl(2)(3-bromoquinoline)(quinoline)] and an investigation of the stabilities and interconversion of the rotamer forms of these complexes. Both head-to-head (HTH) and head-to-tail (HTT) rotamer forms are found in the crystal structure of cis-[PtCl(2)(quinoline)(2)]. The NOESY NMR spectrum of cis-[PtCl(2)(quinoline)(2)] in dmf-d(7) at 300 K is consistent with conformational exchange brought about by rotation about the Pt-N(quinoline) bonds. H.H nonbonded distances between H atoms of the two different quinoline ligands were determined from NOESY data, and these distances are in accord with those observed in the crystal structure and derived from molecular mechanics models. cis-[PtCl(2)(3-bromoquinoline)(quinoline)] was prepared to alleviate the symmetry-imposed absence of inter-ring H2/H2 and H8/H8 NOESY cross-peaks for cis-[PtCl(2)(quinoline)(2)]. Molecular mechanics calculations on the complexes show the HTT rotamers to be 1-2 kJ mol(-)(1) more stable than the HTH forms, consistent with the (1)H spectra where the intensities of resonances for the two forms are approximately equal. Variable-temperature (1)H NMR spectra of cis-[PtCl(2)(quinoline)(2)] in dmf-d(7) indicate a rotational energy barrier of 82 +/- 4 kJ mol(-)(1). Variable-temperature (1)H NMR spectra indicate that the Br substituent on the quinoline ring does not affect the energy barrier to interconversion between the HTT and HTH forms (79 +/- 5 kJ mol(-)(1)). The steric contribution to the rotation barrier was calculated using molecular mechanics calculations and was found to be approximately 40 kJ mol(-)(1), pointing to a possible need for an electronic component to be included in future models.

Entities:  

Year:  2001        PMID: 11399172     DOI: 10.1021/ic001278v

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  7 in total

Review 1.  Synthetic methods for the preparation of platinum anticancer complexes.

Authors:  Justin J Wilson; Stephen J Lippard
Journal:  Chem Rev       Date:  2013-11-27       Impact factor: 60.622

2.  Anticancer Activity of Self-Assembled Molecular Rectangles via Arene-Ruthenium Acceptors and a New Unsymmetrical Amide Ligand.

Authors:  Anurag Mishra; Hyunji Jung; Jeong Woo Park; Hong Kyeung Kim; Hyunuk Kim; Peter J Stang; Ki-Whan Chi
Journal:  Organometallics       Date:  2012-04-13       Impact factor: 3.876

3.  Nucleotide Binding Preference of the Monofunctional Platinum Anticancer-Agent Phenanthriplatin.

Authors:  Imogen A Riddell; Timothy C Johnstone; Ga Young Park; Stephen J Lippard
Journal:  Chemistry       Date:  2016-04-25       Impact factor: 5.236

4.  trans-Dichloridobis(quinoline-κN)palladium(II).

Authors:  Kwang Ha
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-01-14

5.  trans-Dichloridobis(quinoline-κN)platinum(II).

Authors:  Kwang Ha
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-04-04

6.  cis-Dichloridobis(quinoline-κN)-platinum(II) nitro-methane monosolvate.

Authors:  Kwang Ha
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-03-28

7.  Crystal structure of hexa-kis-(dimethyl sulfoxide-κO)cobalt(II) bis-[tri-chlorido-(quinoline-κN)cobaltate(II)].

Authors:  Tyler K Brescia; Kaltrina Mulosmani; Shivani Gulati; Demosthenes Athanasopoulos; Rita K Upmacis
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2018-02-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.